Latest Prempro News

Rising Star: DLA Piper's Christopher Campbell ... when Campbell led the company's science defense and Daubert strategy in multidistrict litig...


Rising Star: DLA Piper's Christopher Campbell
… when Campbell led the company's science defense and Daubert strategy in multidistrict litigation involving more than 10,000 plaintiffs claiming they had developed breast cancer or other illnesses from the hormone therapy drugs Prempro or Premarin.
Read more on Law360 (subscription)

Leave a Reply